Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 32,000 full-time employees.  The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.

Viatris, Inc. adalah perusahaan kesehatan global yang bergerak dalam penyediaan produk kesehatan dan farmasi. Perusahaan ini berkantor pusat di Canonsburg, Pennsylvania dan saat ini mempekerjakan 32.000 karyawan penuh waktu. Segmen perusahaan meliputi Pasar Yang Berkembang, Tiongkok Besar, JANZ, dan Pasar Berkembang. Segmen Pasar Yang Berkembang mencakup operasi utamanya di Amerika Utara dan Eropa. Segmen Tiongkok Besar mencakup operasi di Tiongkok, Taiwan, dan Hong Kong. Segmen JANZ mencerminkan operasi di Jepang, Australia, dan Selandia Baru. Segmen Pasar Berkembang mencakup keberadaannya di lebih dari 125 negara dengan pasar yang sedang berkembang dan ekonomi yang baru muncul, termasuk di Asia, Afrika, Eropa Timur, Amerika Latin, dan Timur Tengah, serta waralaba obat Antiretroviral (ARV) perusahaan. Saluran dan kemampuan penelitian dan pengembangannya mencakup keahlian dalam formulasi, pengembangan perangkat, toksikologi, analitik, klinis, bioanalitik, urusan medis, keamanan produk, dan manajemen risiko di berbagai area terapeutik. Perusahaan ini memproduksi dosis padat oral, injeksi, dan produk dengan bentuk dosis yang kompleks.

Viatris

NVIDIA

Apple

Google

Microsoft

Amazon

Broadcom

Meta Platforms

Taiwan Semiconductor

Tesla

Berkshire Hathaway

Walmart

Eli Lilly

JPMorgan

Visa

Oracle

Exxon Mobil

MasterCard

Johnson & Johnson

Netflix

ASML

SPDR S&P500 ETF

Palantir

AbbVie

Bank of America

Costco

Alibaba

Home Depot

Procter & Gamble

General Electric

Cisco

Chevron

Vanguard Total Stock Market ETF

UnitedHealth Group

Coca-Cola

Wells Fargo

Morgan Stanley

Caterpillar

AstraZeneca

Goldman Sachs

Toyota

American Express

Micron Technology

Novartis

Merck

Salesforce

T-Mobile

Philip Morris

Raytheon Technologies

Royal Bank of Canada

McDonald's

Abbott

Applied Materials

Novo Nordisk

Shell

Shopify

Intuitive Surgical

Invesco QQQ Trust

PepsiCo

Citigroup

Lam Research

Intel

Uber

Disney

Linde PLC

QUALCOMM

Blackstone

Intuit

Amgen

AT&T

ServiceNow

Verizon

NextEra Energy

Charles Schwab

Sony

BlackRock

Accenture

Texas Instruments

Booking Holdings

Danaher

Banco Santander

Arista Networks

Boeing

Gilead Sciences

S&P Global

Toronto-Dominion Bank

Capital One

Pfizer

Unilever

Boston Scientific

TotalEnergies

Union Pacific

Adobe

Lowe's

Palo Alto Networks

Saham Viatris

Tentang Viatris

Statistik Kunci